Home
About
Overview
Sharing Data
ORCID
Help
History (13)
The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.
Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
Oseltamivir dosing for influenza infection in premature neonates.
Medication Safety + Mobile Health = Patient Engagement in CKD.
Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis.
Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2023 08; 10(8):1296-1304.
View in:
PubMed
subject areas
Amyotrophic Lateral Sclerosis
Deglutition
Dextromethorphan
Humans
Quinidine
Speech
authors with profiles
Terrie Vasilopoulos